A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

  • Maria Victoria Humbert
  • , Precious Chinonyerem Opurum
  • , Nathan J. Brendish
  • , Stephen Poole
  • , Peijun He
  • , Ioannis Katis
  • , Jerry Quaye
  • , Yaw Bediako
  • , Patrick Jacques Duriez
  • , Robert W. Eason
  • , Collin Sones
  • , Osbourne Quaye
  • , Gordon A. Awandare
  • , Myron Christodoulides
  • , Tristan W. Clark
  • , Peter K. Quashie
  • , Christopher J. McCormick

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries'. Together they form a unique fingerprint.

Immunology and Microbiology

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences

Psychology